Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study.
暂无分享，去创建一个
N. Girard | O. Molinier | P. Souquet | F. Bonnetain | M. Wislez | C. Lamour | C. Audigier-Valette | A. Vergnenègre | I. Monnet | F. Blanchon | N. Taguieva-Pioger